Trial
NCT03997903
Imatinib for Pain in Sickle Cell Anemia
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
Purdue University; Children's Hospital Medical Center, Cincinnati
Condition
Sickle Cell Disease
Intervention
Imatinib Mesylate
Why stopped
low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-29